VRCA

NASDAQ 已收盘

Verrica Pharmaceuticals

2.74 USD
▼-0.14-5.03%
盘后 2.73 -0.36%
2026-11-20
市值
$47.07M
市盈率
—
EPS
-2.22
股息率
—
52 周区间
2.73 – 9.82
成交量
127.03K
Beta
1.67
目标价
13.67
52W 低 2.7352W 高 9.82
价格走势

公司简介

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of...